An estimated 102 million Americans have cholesterol levels that are considered borderline high-risk.1 This staggering fact makes lowering cholesterol one of the most imperative things to do to promote overall heart health. Unfortunately, too few people understand the essential steps in reaching this goal. Metamucil and Dr. Michael Roizen, Chairman of the Wellness Institute at Cleveland Clinic and host of the upcoming PBS series, “Younger You,” have joined to present the “Five Things Every American Needs to Do to Lower Their Cholesterol” to encourage Americans to lead a proactive lifestyle with small modifications and dietary changes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/metamucil/48409/
An estimated 102 million Americans have cholesterol levels that are considered borderline high-risk.1 This staggering fact makes lowering cholesterol one of the most imperative things to do to promote overall heart health. Unfortunately, too few people understand the essential steps in reaching this goal. Metamucil and Dr. Michael Roizen, Chairman of the Wellness Institute at Cleveland Clinic and host of the upcoming PBS series, “Younger You,” have joined to present the “Five Things Every American Needs to Do to Lower Their Cholesterol” to encourage Americans to lead a proactive lifestyle with small modifications and dietary changes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/metamucil/48409/
Launching today, the Safe Firearms Storage campaign encourages firearms owners to make safe firearms storage a priority. According to a study by the RAND Corporation using statistics from the United States Centers for Disease Control and Prevention, approximately 1.4 million homes have firearms stored in a way that makes them accessible to the wrong hands – children, at–risk youth, potential thieves, and those who intend to harm themselves or others.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7111651-national-crime-prevention-council-family-firearms-safety-campaign
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
The nation’s obesity numbers continue to climb, yet surprisingly many Americans are falling short on key nutrients that could put their health at risk.1,2,3 To address the obesity epidemic the nation faces – especially among children – the federal government released the 2010 Dietary Guidelines for Americans, research-based nutrition guidance that aims to “prevent and/or reduce overweight and obesity through improved eating and physical activity behaviors.”3
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nationaldairycouncil/47923/
To help Americans determine their risk for chronic diseases and get them on a path to better health, CVS/pharmacy announced today the launch of the 2011 “To Your Health” program, offering free preventive health screenings at more than 800 events in communities across the country. The program will get underway in Houston on Saturday, March 5th, and continue in Dallas, Los Angeles, Washington D.C., Atlanta, Philadelphia, Chicago and Miami.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/48303/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
The National Climate Assessment: Climate Change Impacts in the United States concludes that warmer and drier conditions have already contributed to increasing wildfire events across the western United States, and future increases are projected in some regions. Already this year, there have been over 44,000 wildfires that have damaged or destroyed almost 8.5 million acres. Long periods of record high temperatures are associated with droughts that contribute to dry conditions and drive wildfires in some areas.
USDA Secretary Vilsack recently stated, “This year, we are experiencing yet another devastating wildfire season, particularly in the drought-ravaged West. Climate change, drought, fuel buildup, insects and disease are increasing the severity of unprecedented wildfire in America's forests and rangelands, which impacts the safety of people, homes and communities. Development close to forests has also increased the threat to property, with more than 46 million homes in the United States, or about 40 percent of our nation's housing, potentially at risk from wildfire.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7607931-fema-national-prepareathon/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
Every 33 seconds a child under 13 is involved in a car crash in the United States, according to 2014 data from the U.S. Department of Transportation’s National Highway Traffic Safety Administration (NHTSA). Safety seats, if used correctly, can dramatically reduce the risk of fatality or injury. But 59 percent of car seats are misused in a way that could reduce their effectiveness, and over one-third of children killed in car crashes were completely unrestrained at the time of the crash. Today, NHTSA and the Ad Council unveiled a new series of public service advertisements (PSAs) to educate parents and caregivers about the importance of selecting the right seat for their child’s age and size, and to remind them that car seats, booster seats and seat belts offer the best protection for children in crashes and help save lives.
“Life can change in an instant. We want parents and caregivers to prepare for the unexpected, rather than face their worst nightmare,” said Dr. Mark Rosekind, NHTSA administrator. “Buckling up a child correctly and in the right seat is the best protection any parent can do to see their child walk away unharmed from a car crash.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7774451-ad-council-find-the-right-seat/
As global organizations grapple with a more technologically intensive and complex agenda, fissures in traditional approaches to talent management and leadership development are increasingly visible. This was a key theme that emerged at ON Talent, an invitation-only discussion hosted at Deloitte University where leading names in talent argued that the prevailing models of talent development no longer hold. New models like the corporate lattice that are better attuned to the times must be adopted or the risk of HR becoming less relevant is high.
“The system is broken,” said Annmarie Neal, founder of the Center for Leadership Innovation. “If the economic models of the last era of business won’t translate to today’s environment, why would our organizational and talent models translate? In fact, the way we have traditionally approached talent can be an impediment in the 21st century.
Easter Seals this morning released a new report Our Nation’s Children at Risk: A State-by-State Report on Early Intervention during its 2011 International Convention currently being held in Washington, D.C. In meetings with Members of Congress on The Hill today, more than 300 Easter Seals volunteers, staff and families with disabilities will share both the report’s findings and a petition with nearly 40,000 signatures urging legislators to invest in young children.
The new report details how well each state takes care of its youngest children with disabilities and delays. The unfortunate news: infants and toddlers in nearly every state continue to fall behind, many will never catch up.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/easterseals/49505/
